EUVIMEDEUVIMED entdecken
Open Access

Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension

Hongyang Pi iD, Lu Xia iD, Olivier Boucherat iD, Karthik Suresh iD, Anna R Hemnes iD, Sébastien Bonnet iD, Claudio A Bravo iD, Laura Oppegard iD, Samuel G Rayner iD, Ali Shojaie iD, Sina A Gharib iD, Peter J Leary iD

Circulation: Heart Failure · 2024

DOI: 10.1161/circheartfailure.124.012067 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Circulation: Heart Failure, 2024. Verfasst von Hongyang Pi und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle. Hauptthemen laut MEDLINE: Proteomics, Pulmonary Arterial Hypertension, Natriuretic Peptide, Brain, Peptide Fragments. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIAID NIH HHS, NHLBI NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Pulmonary arterial hypertension (PAH) is a disease of progressive right ventricular (RV) failure with high morbidity and mortality. Our goal is to investigate proteomic features and pathways associated with RV-focused outcomes including mortality, RV dilation, and NT-proBNP (N-terminal pro-B-type natriuretic peptide) in PAH. METHODS: Participants in a single-institution cohort with 3 years of follow-up underwent proteomic profiling of their plasma using 7288 aptamers (targeting 6467 unique human proteins). Partial least squares discriminant analysis was performed to assess global protein variation associated with mortality, RV dilation, and NT-proBNP levels. Differentially abundant proteins and enriched pathways associated with outcomes were identified following baseline adjustments. RV vulnerability models estimated associations for individuals with similar afterload following adjustment for pulmonary vascular resistance. RESULTS: A total of 117 participants with PAH were included. Partial least squares discriminant analysis of the proteome showed clear separation between survivors and nonsurvivors, participants with dilated versus nondilated RVs, and across NT-proBNP levels. Proteins and pathways involving the ECM (extracellular matrix) were upregulated in participants who died during follow-up, those with severe RV dilation, and those with higher levels of NT-proBNP. Pulmonary vascular resistance adjustment reinforced the importance of ECM proteins in the association with RV vulnerability, independent of afterload. These findings were confirmed in independent PAH cohorts with available plasma proteomics and RV tissue gene and protein expression. CONCLUSIONS: Distinct plasma proteomic profiles are associated with mortality, RV dilation, and NT-proBNP in PAH. Proteins and pathways governing tissue remodeling are strongly associated with poor outcomes, may mediate RV vulnerability to right heart failure, and represent promising candidates as biomarkers and potential therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProteomicsPulmonary Arterial HypertensionNatriuretic Peptide, BrainPeptide FragmentsVentricular Dysfunction, RightHumansMaleFemaleMiddle AgedBiomarkersAdultVentricular Function, RightAgedHeart VentriclesVentricular RemodelingPrognosis

Stichwörter der Autor:innen

biomarkersextracellular matrixproteomicspulmonary arterial hypertensionright ventricleright-sided heart failuresurvivors

Substanzen

Natriuretic Peptide, BrainPeptide Fragmentspro-brain natriuretic peptide (1-76)Biomarkers

Autor:innen und Institutionen

  • Department of Medicine (H.P., S.G.R., S.A.G., P.J.L.), University of Washington, Seattle.
  • Department of Statistics and Probability, Michigan State University, East Lansing (L.X.).
  • Department of Medicine, Université Laval, Québec, QC, Canada (O.B., S.B.).
  • Department of Medicine, Johns Hopkins University, Baltimore, MD (K.S.).
  • Department of Medicine, Vanderbilt University, Nashville, TN (A.R.H.).
  • Division of Cardiovascular Disease, Medical City Healthcare, Institute for Advanced Cardiac Care, Dallas, TX (C.A.B.).

ORCID-Profile: Hongyang Pi, Lu Xia, Olivier Boucherat, Karthik Suresh, Anna R Hemnes, Sébastien Bonnet, Claudio A Bravo, Laura Oppegard, Samuel G Rayner, Ali Shojaie, Sina A Gharib, Peter J Leary

Förderung

  • NIAID NIH HHS
  • NHLBI NIH HHS
  • NIGMS NIH HHS
  • NIDDK NIH HHS
  • NCATS NIH HHS

Zitieren

APA

Pi, H., Xia, L., Boucherat, O., Suresh, K., Hemnes, A. R., Bonnet, S., Bravo, C. A., Oppegard, L., Rayner, S. G., Shojaie, A., Gharib, S. A., & Leary, P. J. (2024). Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation: Heart Failure. https://doi.org/10.1161/circheartfailure.124.012067

Vancouver

Pi H, Xia L, Boucherat O, Suresh K, Hemnes AR, Bonnet S, et al. Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension. Circulation: Heart Failure. 2024. doi:10.1161/circheartfailure.124.012067

BibTeX
@article{Pi2024,
  author = {Pi, Hongyang and Xia, Lu and Boucherat, Olivier and Suresh, Karthik and Hemnes, Anna R and Bonnet, Sébastien and Bravo, Claudio A and Oppegard, Laura and Rayner, Samuel G and Shojaie, Ali and Gharib, Sina A and Leary, Peter J},
  title = {Proteomic Signatures of Right Ventricular Outcomes in Pulmonary Arterial Hypertension},
  journal = {Circulation: Heart Failure},
  year = {2024},
  doi = {10.1161/circheartfailure.124.012067}
}
Kostenlos starten →